gene therapy
gene therapy is a pharmaceutical drug with 19 clinical trials. Currently 3 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
13
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
8 of 10 finished
20.0%
2 ended early
3
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
A Phase I Study of CREPT-618 in Locally Advanced HCC
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
Gene Therapy for IGHMBP2-Related Diseases
Clinical Trials (19)
A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
A Phase I Study of CREPT-618 in Locally Advanced HCC
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
Gene Therapy for IGHMBP2-Related Diseases
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
The World Federation of Hemophilia Gene Therapy Registry
Gene Therapy in Treating Patients With Primary Brain Tumors
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Gene Therapy for Gyrate Atrophy
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19